Tip Report 57
Clinicians is upgrade those local prostate malignant tumors people considering focal therapy or HIFU these particular procedures lack sturdy proof efficacy. (Expert Thoughts)
Conversation
The Panel recognizes that novel therapies including HIFU and focal prostate ablation may provide QoL advantages for patients in comparison to surgery and radiotherapy. However, there is a lack of consensus on objective response criteria, very limited long-term oncologic data, and, importantly, no comparative effectiveness data versus traditional treatments available. For patients with intermediate- and high-risk disease treated with HIFU, neoadjuvant ADT has been demonstrated to reduce PSA recurrence, but long-term oncologic effectiveness is unknown. 262 For focal therapy, initial reports with short term follow-up suggest effective disease eradication in the treated area of appropriately selected patients.ادامه خواندن